Mitchell Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40,755
Closed -$3.8M 122
2022
Q4
$3.8M Sell
40,755
-274
-0.7% -$26.4K 1.05% 26
2022
Q3
$3.91M Buy
41,029
+791
+2% +$78.3K 1.11% 22
2022
Q2
$3.73M Buy
40,238
+1,516
+4% +$148K 1.04% 27
2022
Q1
$3.92M Buy
38,722
+1,164
+3% +$122K 0.88% 34
2021
Q4
$3.87M Buy
37,558
+866
+2% +$80K 0.78% 42
2021
Q3
$3.11M Buy
36,692
+1,122
+3% +$94K 0.7% 50
2021
Q2
$2.97M Buy
35,570
+2,584
+8% +$212K 0.65% 56
2021
Q1
$2.48M Buy
32,986
+3,828
+13% +$279K 0.61% 65
2020
Q4
$1.99M Buy
29,158
+1,466
+5% +$95.4K 0.5% 67
2020
Q3
$1.62M Sell
27,692
-146
-0.5% -$9.09K 0.47% 64
2020
Q2
$1.81M Buy
27,838
+444
+2% +$28K 0.58% 58
2020
Q1
$1.63M Buy
27,394
+6,397
+30% +$427K 0.63% 54
2019
Q4
$1.56M Buy
20,997
+4,374
+26% +$307K 0.5% 69
2019
Q3
$1.05M Buy
16,623
+7,970
+92% +$472K 0.35% 78
2019
Q2
$472K Sell
8,653
-537
-6% -$28.9K 0.16% 107
2019
Q1
$496K Buy
9,190
+97
+1% +$5.99K 0.18% 103
2018
Q4
$596K Buy
+9,093
New +$679K 0.25% 82

Other funds holding CVS

Mitchell Capital Management's CVS Position: Q1 2023 in Review

Mitchell Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 40,755 shares — an estimated $3.8M sold.

Mitchell Capital Management first reported a position in CVS in Q4 2018 and held it in 17 quarters. The position peaked at $3.92M in Q1 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Mitchell Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Mitchell Capital Management sold 40,755 CVS Health shares in Q1 2023, an estimated $3.8M.
  • Mitchell Capital Management first reported a position in CVS Health in Q4 2018 and held it in 17 quarters.
  • Mitchell Capital Management's CVS Health position peaked at $3.92M in Q1 2022.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Mitchell Capital Management's 13F filing for Q1 2023, filed 8 May 2023.